Nevertheless, the advantages of activation of the Nrf2 are supported by the rescue of the epithelial barrier dysfunction in asthma models and cigarette smoke-induced epithelial disruption and subsequent improvement of the pulmonary dysfunction (Sussan et al., 2015; Tharakan et al., 2016). The gene discussed is NFE2L2; the disease is asthma.